PubMed Trending Research Digest — October 04, 2026

Automated digest · 97 articles · 15 research areas · October 04, 2026

Overview

Across this week’s papers, a dominant theme is mechanism-informed heterogeneity—in both disease biology and clinical decision-making. Reviews and studies in IBS, IBD, atopic dermatitis, RA, SLE, and vaccine-safety epistemics emphasize that conditions previously treated as single entities are better understood as collections of subtypes driven by distinct pathways (e.g., gut–brain dysregulation, immune costimulatory signaling, immune–inflammation biomarkers, and context-dependent risk interpretation). In parallel, oncology papers repeatedly show that outcomes depend on molecular state (e.g., condensate behavior in α-synuclein variants, 3D genome architecture in AML, stress-state regulators in PDAC CAR-T response, and fibrosis/immune crosstalk in HCC), motivating stratified and sequencing-based strategies rather than one-size-fits-all treatment.

A second major thread is next-generation tools for prediction and targeting. Methodological advances span deep learning for schizophrenia risk from exome data, dynamic AI for predicting extrahepatic organ failure in decompensated cirrhosis, plasma proteomic “organ clocks” for long-term mortality, and minimally invasive liquid-biopsy approaches using urine cfRNA. On the therapeutic side, multiple studies highlight more precise interventions: NS1-targeting antivirals for influenza, state-dependent channel modulation insights for KCNQ1, senolytics for fibrotic MASH, GLP-1–pathway mechanistic kidney protection in T2D/CKD, and regenerative/hormone replacement approaches using stem-cell-derived ACTH cells.

Finally, several papers connect microbial and metabolic inputs to chronic disease trajectories. Work on microbiome–toxin interactions (ETBF with Fusobacterium), fungal metabolite drivers of MASLD-HCC (Rhizopus → kynurenic acid), and climate-driven changes in mosquito-borne transmission all reinforce that external biological and environmental pressures can shape long-term risk. Together with studies on metabolic reprogramming in diabetic vascular disease and intergenerational epigenetic programming from maternal obesity, the digest underscores a unifying message: improving health outcomes will increasingly require integrating molecular mechanisms, biomarkers, and real-world context into prevention and therapy.

---

Gut–Brain Axis & Functional GI Disorders

Effects of Yoga on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

This systematic review and meta-analysis evaluated randomized controlled trials of yoga in people with rheumatoid arthritis (RA) to determine effects on psychological function and inflammation. Across included studies, yoga was associated with improvements in psychological outcomes and reductions in inflammatory measures compared with control interventions. These findings support yoga as a potentially beneficial adjunct non-pharmacologic strategy for RA symptom burden and inflammation, though the evidence base depends on the quality and heterogeneity of the underlying RCTs.

Suresh A, Ramaswamy S, Silambanan S et al. · International journal of rheumatic diseases · (2026) · View on PubMed ↗

When Food Avoidance Meets Compatible Diagnostic Criteria: Avoidant/Restrictive Food Intake Disorder Features in Irritable Bowel Syndrome.

This study investigated avoidant/restrictive food intake disorder (ARFID) features in adults with irritable bowel syndrome (IBS) using both questionnaire screening and DSM-5-compatible criteria. It found that ARFID-like symptoms can be overestimated when using the Nine Item ARFID Screen alone, and it compared prevalence and associated characteristics between ARFID-like symptoms and DSM-5-compatible ARFID determined by medical chart review. Clinically, the findings support using compatible diagnostic criteria rather than screening-only definitions when assessing clinically meaningful ARFID in IBS patients.

Mikhael-Moussa H, Aupetit A, Guérin O et al. · Neurogastroenterology and motility · (2026) · View on PubMed ↗ · Free PDF ↗

Irritable bowel syndrome.

This review studied irritable bowel syndrome (IBS) as a gut–brain interaction disorder in the general population, focusing on epidemiology and mechanistic heterogeneity across motility, visceral sensitivity, epithelial barrier function, neuroimmune activation, and the gut microbiome. It found that IBS affects roughly 4–11% of people worldwide and is increasingly understood as a heterogeneous condition driven by dysregulated bidirectional signaling within the gut–brain axis rather than a single structural disease process. Clinically, this supports more mechanism-informed, stratified approaches to diagnosis and therapy for IBS.

Chang L, Corsetti M, Chey WD et al. · Nature reviews. Disease primers · (2026) · View on PubMed ↗

---

Antiviral Drug Discovery (Influenza & Beyond)

Identifying a broad-spectrum influenza inhibitor that blocks multiple functions of viral NS1 protein.

This study investigated the marine-derived influenza A virus (IAV) NS1 inhibitor HDN2398 in multiple cell lines and in female mice, targeting the viral nonstructural protein 1 (NS1). HDN2398 showed broad-spectrum anti-IAV activity that was superior to oseltamivir and baloxavir by blocking NS1 dimerization and NS1 binding to dsRNA, thereby impairing NS1 nucleolar localization, viral mRNA splicing, and nuclear export via disruption of NS1–nucleolin/NS1–NXF1 interactions. These findings are significant because they validate NS1 as a multi-function antiviral target and identify HDN2398 as a potential next-generation broad-spectrum anti-influenza candidate.

Zhang Y, Luo Y, Gai W et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

---

Machine Learning for Psychiatric Genetics

End-to-end deep learning methods for genetic risk prediction of schizophrenia.

This study evaluated end-to-end genome interpretation neural network models for genetic risk prediction of schizophrenia using whole exome sequencing data from 6,135 cases and 6,245 controls. It found that nonlinear neural networks significantly outperformed conventional additive (linear) genetic risk models when sample size was sufficient, improving capture of complex nonlinear effects such as epistasis. Scientifically, this supports using deep learning on exome data to build more accurate schizophrenia polygenic risk prediction frameworks for clinical translation.

Verplaetse N, Moreau Y, Raimondi D · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

---

Neurodegeneration Mechanisms & Biomarkers

Mdivi-1 regulates mitochondrial fission and function via the CaMK2/Drp1 pathway in amyotrophic lateral sclerosis.

This study tested whether mitochondrial division inhibitor-1 (Mdivi-1), a Drp1 fission inhibitor, modulates mitochondrial fission and function through the CaMK2/Drp1 pathway in amyotrophic lateral sclerosis (ALS) models. In NSC34 cells expressing mutant SOD1^G93A and in SOD1^G93A transgenic mice, ALS models showed mitochondrial dysfunction and oxidative stress, and Mdivi-1 regulated mitochondrial fission/function via CaMK2/Drp1 signaling (specific mechanistic readouts truncated). These findings support a pathway-specific rationale for targeting Drp1-mediated mitochondrial quality control in ALS.

Shai Y, Alam M, Dong X et al. · Neuroscience · (2026) · View on PubMed ↗

Nitrate-responsive Sialin2 couples stress granule assembly and clearance to maintain neuronal homeostasis.

The study examined how nitrate-responsive Sialin2 (SLC17A5) regulates stress granule (SG) assembly and clearance in neuronal cells across the stress–recovery cycle. Sialin2 undergoes liquid–liquid phase separation during acute stress to co-assemble with G3BP-centered scaffolds for SG formation, and during recovery it preserves SG liquid-like dynamics while promoting autophagy-linked clearance; Sialin2 loss delays SG resolution and promotes retention of amyotrophic lateral sclerosis–linked SG material. This links an extracellular nitrate-responsive transporter to intracellular SG homeostasis, suggesting a mechanistic axis for neuronal resilience and potential therapeutic targeting in neurodegenerative disease.

Li X, Cao Z, Jiang O et al. · Developmental cell · (2026) · View on PubMed ↗

Lysosomal multi-omics reveals altered sphingolipid catabolism associated with lysosomal dysfunction in the aging brain.

This study used lysosomal multi-omics to characterize age-associated changes in sphingolipid catabolism and lysosomal dysfunction in the murine brain. By performing mass spectrometry of lipidome and proteome from lysosomal fractions of mouse cortex across ages 3 to 24 months and applying multi-omics factor analysis (MOFA), it found age-dependent increases in lysosomal abundance of lipid/protein myelin components and evidence for altered sphingolipid catabolism favoring degradation of sphingolipids. The significance is improved molecular understanding of how lysosomal dysfunction contributes to brain aging and potentially neurodegenerative risk.

Sarkar C, Chen Y, Nguyen DP et al. · Cell reports · (2026) · View on PubMed ↗ · Free PDF ↗

In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson’s disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation.

This case study used seed amplification assay to detect pathological α-synuclein and TDP-43 in skin and olfactory mucosa from a patient with a Parkinson’s disease-like phenotype carrying the GRN p.Thr272Serfs*10 frameshift mutation. The assays suggested mixed TDP-43 and α-synuclein co-pathology, consistent with later prodromal frontotemporal dementia. The findings support combined peripheral sampling and seed amplification as a minimally invasive strategy to characterize underlying neurodegenerative pathology in GRN-related disease.

Caroppo P, Aprea V, Villa C et al. · Molecular neurodegeneration · (2026) · View on PubMed ↗ · Free PDF ↗

Different functional connectivity gradients reflect aging and Alzheimer’s disease.

This study analyzed functional connectivity in two independent cohorts—BioFINDER-2 (n=973) and ADNI (n=129)—to characterize how aging and Alzheimer’s disease alter whole-cortex communication dynamics. It found that connectivity changes associated with aging and AD align with distinct hierarchical brain communication axes, with early AD pathology and later cognitive decline both reflected in these gradient patterns. The work is significant because it provides a framework for tracking disease progression using whole-brain connectivity gradients rather than isolated network measures.

Rittmo J, Franzmeier N, Strandberg O et al. · Nature neuroscience · (2026) · View on PubMed ↗ · Free PDF ↗

Dual effect of α-synuclein disease variants on condensate formation.

This study examined how Parkinson’s disease–associated α-synuclein variants affect biomolecular condensate formation, focusing on specific mutations including E46K and E83Q. It found that some disease variants fail to form α-synuclein condensates while others (notably E46K and E83Q) enhance condensate formation, indicating a dual effect of α-synuclein disease variants on phase separation/condensate dynamics. This is significant because it links variant-specific condensate behavior to synucleinopathy mechanisms and may help explain heterogeneity in aggregation and disease progression.

Chandran A, Agarwal A, Wang T et al. · Nature communications · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗

---

Ubiquitin/Notch Signaling & Fibrosis

FBXW7 mitigates hepatic fibrosis by degrading NOTCH1 to transcriptionally silence SEMA3G in liver sinusoidal endothelial cells.

This study investigated whether the E3 ubiquitin ligase FBXW7 mitigates hepatic fibrosis by degrading NOTCH1 and transcriptionally silencing SEMA3G in liver sinusoidal endothelial cells (LSECs), using endothelial-specific Fbxw7 knockout mice across three fibrosis models. It found that loss of FBXW7 worsened fibrosis, promoted LSEC capillarization, and increased hepatic stellate cell activation, with transcriptomic analysis identifying Sema3g as a key upregulated downstream gene in FBXW7-deficient LSECs. The results are clinically relevant because they position the FBXW7–NOTCH1–SEMA3G axis as a potential therapeutic pathway to suppress hepatic fibrosis.

Yan C, Dong J, Sun Y et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

---

Vascular Calcification & Atherosclerosis

Gene regulatory network analysis identifies auranofin as an anti-atherosclerotic drug.

This gene regulatory network (GRN) study used a GRN-driven drug-repurposing strategy integrating transcriptional signatures from silencing key human arterial wall foam cell regulators with LINCS drug-induced gene expression profiles. Computational prioritization and in vitro validation identified auranofin, an FDA-approved gold salt, as an anti-atherosclerotic candidate that reduces foam cell–related processes. The significance lies in providing a mechanistic, systems-biology route to repurpose an existing drug for coronary artery disease targeting foam cell biology.

Amadori L, Calcagno C, Kaur R et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Vascular calcification: pathogenic mechanisms, signaling crosstalk and translational therapeutics.

This review studied vascular calcification (VC) mechanisms, emphasizing signaling crosstalk and translational therapeutic strategies in the context of arterial hydroxyapatite deposition. It found that VC is a dynamically regulated process driven by disrupted balance between pro-calcific and anti-calcific pathways under pathological stimuli, with multiple molecular signaling networks interacting to drive disease progression. The significance lies in consolidating mechanistic targets and signaling pathways that could be leveraged for therapeutic development to reduce cardiovascular morbidity and mortality.

Hua R, Qiao B, Liu X et al. · Signal transduction and targeted therapy · (2026) · View on PubMed ↗ · Free PDF ↗

---

Pyroptosis & Gasdermin Biology

The gasdermin family: from pyroptosis mechanisms to therapeutic targets.

This review studied the gasdermin (GSDM) protein family as executioners of pyroptosis and as regulators of additional, sometimes pyroptosis-independent, cellular processes across health and disease. It found that GSDMs drive inflammatory cell death via plasma membrane rupture and release of cytokines such as IL-1β and IL-18, while also contributing to functions including mucus secretion, bone resorption, and mitochondrial metabolism. This is significant because it frames GSDMs as therapeutic targets and summarizes activation/regulation mechanisms that can guide drug discovery for inflammatory and degenerative diseases.

Xu W, Liu S, Yu Z et al. · Signal transduction and targeted therapy · (2026) · View on PubMed ↗ · Free PDF ↗

---

Proteomics & Biological Aging Clocks

Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality.

This study benchmarked plasma proteomic “organ clocks” against multimodal ageing biomarkers for associations with 16-year all-cause mortality in the Lothian Birth Cohort 1936 (LBC1936; 861 participants, 444 deaths) using Cox regression. Proteomic organ clock measures showed mortality associations that were systematically compared to established multimodal ageing biomarkers. These findings support using plasma proteomics to quantify biological ageing and improve long-term risk stratification beyond chronological age.

Pyrgioti M, Eguiagaray IM, Redmond P et al. · Aging cell · (2026) · View on PubMed ↗

---

Targeted Oncology Trials (KRAS/Immunotherapy and Beyond)

Urine cell-free RNA for bladder cancer detection and treatment response prediction.

This phase III GLOW trial reported 67-month long-term outcomes of first-line ibrutinib–venetoclax versus chlorambucil–obinutuzumab in older/comorbid patients with chronic lymphocytic leukemia (CLL). Ibrutinib–venetoclax improved overall survival (66-month OS 79.0% vs 60.8%; HR 0.46) and reduced grade 3/4 treatment-emergent adverse event–free progression-free survival events (grade 3/4 TEAE-free PFS details truncated). The results strengthen the evidence for ibrutinib–venetoclax as a durable, better-tolerated first-line regimen in a real-world CLL population with high comorbidity burden.

Liu KJ, Shi WY, Nesselbush MC et al. · Nature medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Sex Differences in Mortality Among Patients With Hepatocellular Carcinoma.

This retrospective multicenter cohort study assessed sex differences in overall, liver-related, and non-liver-related mortality among patients with hepatocellular carcinoma (HCC) across 17 centers in 5 countries/regions (2000–2023), using inverse probability of treatment weighting (IPTW) and propensity score matching for balanced comparisons. The key finding was that mortality risk differed by sex after adjustment for baseline characteristics (with the study designed to quantify these differences across mortality subtypes). Scientifically and clinically, the results clarify whether sex is an independent prognostic factor in HCC and can inform risk prediction and tailored management.

Yan T, Yeh ML, Leong J et al. · JAMA network open · (2026) · View on PubMed ↗ · Free PDF ↗

Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

This 5-year update of a multicenter phase 2 trial evaluated the long-term safety and efficacy of pembrolizumab-GVD—pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin—in transplant-eligible patients with relapsed or refractory classical Hodgkin lymphoma (cHL). The study reported durable outcomes with a very high complete response rate and progression-free survival at 13.5 months, and the update extends these results through 5 years. Clinically, it supports the durability of this chemo-immunotherapy regimen followed by high-dose chemotherapy and autologous stem cell rescue (HDT/ASCR) in this patient population.

Patel K, Shah GL, Schöder H et al. · Blood · (2026) · View on PubMed ↗

SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy.

SUNRAY-02 evaluated olomorasib, a selective next-generation KRAS G12C inhibitor, combined with immunotherapy in patients with stage II–III KRAS G12C-mutant non-small cell lung cancer (NSCLC) after definitive therapy. The trial investigates whether adding olomorasib to immunotherapy can reduce recurrence risk in an early-stage population lacking approved targeted options for KRAS G12C. If effective, this strategy could establish a new targeted-immunotherapy approach for preventing relapse after curative-intent treatment in KRAS G12C–mutant early NSCLC.

Chaft J, Lee JM, Senan S et al. · Future oncology (London, England) · (2026) · View on PubMed ↗ · Free PDF ↗

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

This pooled analysis studied 1,038 patients with resectable stage IIIB-D melanoma treated with neoadjuvant immune checkpoint inhibitors (anti–PD-1–based regimens), BRAF/MEK inhibitors, or ICI plus targeted therapy across 26 international sites. Five-year survival outcomes were reported for these regimen types and for clinical, histopathological, and molecular subgroups, addressing long-term efficacy and postsurgical management gaps. The findings are clinically important for selecting optimal neoadjuvant therapy and anticipating durable survival in stage IIIB-D melanoma.

Long GV, Pires da Silva I, Perry KA et al. · Nature medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial.

This phase 2 randomized clinical trial studied everolimus plus letrozole with or without ribociclib in patients with recurrent endometrial cancer (NCT03008408), with progression-free survival (PFS) as the primary endpoint. In all-comers, adding ribociclib did not significantly improve PFS or overall survival, and toxicity-related discontinuation rates were similar between arms. The significance is that the combination strategy did not demonstrate clear benefit in the overall population, informing future trial design and subgroup-focused development.

How JA, Westin SN, Pham M et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

---

Metabolic Risk & Cardiovascular Prevention (Hypertension/Diabetes/Obesity)

The association between systemic inflammation as measured by calprotectin and autoantibody load in rheumatoid arthritis.

This cross-sectional cohort study in 4521 Scandinavian patients with rheumatoid arthritis (RA) assessed associations between plasma calprotectin (a neutrophil-activity marker) and autoantibody load, including anti-CCP2 and other anti-modified protein autoantibodies (AMPAs), using fluoroenzyme immunoassays. Calprotectin levels showed measurable relationships with RA autoantibody profiles and clinical inflammatory markers such as CRP and ESR. Scientifically, linking calprotectin to autoantibody load helps refine RA phenotyping and may support more integrated biomarker strategies for disease activity and immune-pathway characterization.

Grönwall C, Alm LM, Westerlind H et al. · Arthritis & rheumatology (Hoboken, N.J.) · (2026) · View on PubMed ↗ · Free PDF ↗

Oral glucocorticoid dose patterns and organ damage in systemic lupus erythematosus - a nationwide cohort study.

This nationwide Swedish register-based cohort study followed individuals with newly diagnosed systemic lupus erythematosus (SLE) from 2006–2022 to evaluate how oral glucocorticoid (GC) dose patterns over time relate to subsequent organ damage. By modeling long-term GC exposure from pharmacy dispensations, the study identified which dosing time windows/patterns had the strongest association with overall organ damage and with specific domains (ocular, cardiovascular, peripheral vascular, gastrointestinal, diabetes, and malignancy). These results improve risk stratification by clarifying which GC exposure patterns best capture damage risk, supporting more precise GC tapering and monitoring strategies.

Dominicus A, Gomez Á, Nguyen NV et al. · Arthritis & rheumatology (Hoboken, N.J.) · (2026) · View on PubMed ↗ · Free PDF ↗

Leptin-sensitive hypothalamic Lepr+/Glp1r+ neurons limit hyperphagia and weight gain in diet-induced obesity.

This mouse study investigated which hypothalamic neurons remain sensitive to endogenous leptin in diet-induced obesity (DIO) by combining spatial transcriptomics with single-nucleus RNA sequencing. It identified a leptin-sensitive subpopulation defined by co-expression of Lepr and Glp1r (Lepr+/Glp1r+ neurons) that projects to and inhibits orexigenic Agrp neurons, and deletion of Lepr specifically in these neurons disrupted leptin’s anorectic effect and promoted hyperphagia/weight gain. These findings are significant because they pinpoint a neural circuit that could be targeted to restore appetite control in obesity despite leptin resistance to exogenous leptin.

Belmont-Rausch DM, Kapel BS, Tomlinson AJ et al. · The EMBO journal · (2026) · View on PubMed ↗ · Free PDF ↗

Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction.

This study examined how maternal obesity affects offspring metabolic risk by analyzing DNA methylation and chromatin features in oocytes and linking them to intergenerational outcomes. In models of maternal obesity, locus-specific DNA methylation changes in oocytes persisted as intergenerational methylation and transcriptional dysregulation for metabolic genes including Hnf1α, Thra, and Pdk4, even though methylation marks were erased during embryogenesis; H3K36me2 enrichment remained at these loci and single-CpG analysis identified regulatory lan elements. The findings are significant because they provide a mechanistic epigenetic pathway for how maternal metabolic state can program future generations’ metabolic dysfunction.

Han L, Wu Y, Li J et al. · Nature metabolism · (2026) · View on PubMed ↗

Are we at risk of increasing sarcopenia? Implications for osteoarthritis and osteoporosis.

This article reviewed whether sarcopenia prevalence is increasing and discussed implications for osteoarthritis and osteoporosis in the context of changing population risk factors. It argues that while true prevalence trends are hard to quantify due to varying diagnostic frameworks, demographic aging and rising multimorbidity, obesity, hospitalization, surgery, and incomplete recovery likely increase the number of people with low musculoskeletal reserve. Scientifically and clinically, it highlights sarcopenia as a potentially growing contributor to OA/OP risk and underscores the need for harmonized surveillance and prevention strategies.

Pan F, Cicuttini FM · Best practice & research. Clinical rheumatology · (2026) · View on PubMed ↗ · Free PDF ↗

Association of severe liver disease and diabetic retinopathy, retinal imaging phenotypes, and plasma metabolic signatures: A UK biobank study.

Using UK Biobank data (n=499,852), this study examined whether hospitalization-defined severe liver disease (SLD) predicts subsequent hospitalization-defined diabetic retinopathy (DR), and whether shared plasma metabolic signatures and multimodal retinal imaging phenotypes explain part of the association. It applied time-dependent Cox models to quantify the SLD–DR relationship and to identify metabolic and retinal features associated with shared risk (key quantitative results truncated). The work supports a systemic metabolic link between liver disease and diabetic eye complications, informing risk stratification and mechanistic hypotheses.

Zeng Y, Hu H, Rong R et al. · Metabolism: clinical and experimental · (2026) · View on PubMed ↗

Current Understanding of Genetic Architecture of Polyendocrine Metabolic Ovarian Syndrome (PMOS) - 2026 Update.

This 2026 update synthesized the genetic architecture of polyendocrine metabolic ovarian syndrome (PMOS; formerly PCOS) by reviewing NHGRI-EBI GWAS Catalog and PubMed evidence. It identified 17 PMOS GWAS or GWAS meta-analyses with significant loci, totaling 120 genomic regions, with 38 loci replicated across at least two cohorts (replication patterns truncated). The review consolidates current GWAS-derived loci to guide future functional studies and improve genetic risk understanding for PMOS heterogeneity.

Parker C, Urbanek M · Fertility and sterility · (2026) · View on PubMed ↗ · Free PDF ↗

The burden and long-term outcomes of diagnosed and underdiagnosed COPD across diverse communities from high-income, middle-income, and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study.

This multinational PURE cohort study quantified the burden and long-term outcomes of diagnosed versus underdiagnosed COPD across high-, middle-, and low-income countries using spirometry-based airflow obstruction. It followed adults aged 35–70 years from communities in 25 countries and compared outcomes in those with spirometry obstruction who had physician-diagnosed airway diseases but were diagnosed or underdiagnosed for COPD (primary results truncated). The study is significant for global health planning by clarifying how underdiagnosis affects prognosis across diverse settings and income levels.

Duong M, Kang E, Rangarajan S et al. · The Lancet. Global health · (2026) · View on PubMed ↗ · Free PDF ↗

Clinical Practice Guideline for Systemic Antibacterial and Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Cell Transplant Recipients: 2026 Update.

This 2026 Pediatric Oncology Group of Ontario clinical practice guideline update studied systemic antibacterial and antifungal prophylaxis strategies in pediatric patients with cancer and hematopoietic cell transplant (HCT) recipients. Using updated systematic reviews of randomized trials and GRADE methodology, the panel harmonized and revised recommendations for prophylactic antibacterial and antifungal drug use across pediatric oncology and HCT settings. Clinically, it provides standardized, evidence-based prophylaxis guidance intended to reduce infection risk while improving consistency of care in high-risk pediatric populations.

Morgan JE, Patel P, Wolf J et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · (2026) · View on PubMed ↗ · Free PDF ↗

Efficacy and mechanistic insights of dapagliflozin in hypertension management.

This narrative review studied the antihypertensive efficacy and proposed mechanisms of dapagliflozin, an SGLT2 inhibitor, in patients with hypertension—especially those with comorbid type 2 diabetes (T2D), chronic kidney disease (CKD), or heart failure (HF). It found that dapagliflozin produces additional blood pressure–lowering effects across diverse cardiorenal populations, consistent with its broader cardiorenal benefits. Scientifically and clinically, the synthesis supports dapagliflozin as a mechanistically plausible adjunct for BP management in patients with hypertension plus metabolic or cardiorenal disease.

Chen Z, Chunbin W, Zhang H et al. · Clinical and experimental hypertension (New York, N.Y. : 1993) · (2026) · View on PubMed ↗ · Free PDF ↗

Age at Iatrogenic Menopause and Cardiovascular Morbidity and Mortality: A Systematic Review and Meta-Analysis.

This systematic review and meta-analysis evaluated observational studies and randomized trials (searching multiple databases from 2004 to March 2026) to quantify how iatrogenic menopause and the age at iatrogenic menopause relate to cardiovascular morbidity and mortality in women. The analysis specifically tested whether age at iatrogenic menopause modifies cardiovascular outcomes. The findings are significant for counseling and long-term cardiovascular risk management in women who undergo treatment-induced menopause.

Armeni E, Erkan IBO, Kempegowda P · JAMA network open · (2026) · View on PubMed ↗ · Free PDF ↗

Metabolic reprogramming in diabetic panvascular disease: Molecular mechanism and therapeutic strategies.

This review studied the molecular mechanisms of metabolic reprogramming driving diabetic panvascular disease across vascular complications (cardiovascular, cerebrovascular, renal, retinal, and peripheral vascular). It found that hyperglycemia, insulin resistance, and dyslipidemia rewire vascular metabolic pathways through axes such as the polyol pathway, hexosamine pathway, and AGE–PKC signaling, alongside lipotoxicity and amino-acid pathway disruption. The review’s significance is that it frames metabolic reprogramming as a unifying therapeutic target, supporting development of strategies that address shared metabolic drivers rather than treating each complication separately.

Bai Y, Bai Y, Liu S · iScience · (2026) · View on PubMed ↗ · Free PDF ↗

Diet and nutrition in obesity treated with incretin-based therapies: A scientific statement of the Polish Society of Dietetics.

This scientific statement studied nutritional considerations in adults with obesity treated with incretin-based therapies, specifically GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists. It found that incretin therapy can reduce energy intake and cause gastrointestinal adverse effects, leading to risks such as loss of lean/fat-free mass and inadequate protein and micronutrient intake. Clinically, it provides Polish Society of Dietetics guidance to support nutritional care during incretin-based obesity treatment to mitigate these risks.

Kwaśny A, Słoma-Krześlak M, Kostelecki G et al. · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · (2026) · View on PubMed ↗ · Free PDF ↗

Association between extreme temperature events and intrinsic capacity trajectories among middle-aged and older adults: the China Health and Retirement Longitudinal Study (CHARLS).

This study examined whether extreme temperature events are associated with trajectories of intrinsic capacity (IC) among middle-aged and older adults in the China Health and Retirement Longitudinal Study (CHARLS). Using repeated IC assessments across three waves (2011, 2013, 2015) in 1,393 participants aged 45–80 years, the authors evaluated how heat/cold extremes relate to changes in the WHO-defined multidimensional IC score. The results inform public health planning by linking climate-related exposures to healthy aging trajectories over time.

Huang L, Huang Y, Qian B et al. · BMC public health · (2026) · View on PubMed ↗ · Free PDF ↗

Differential efficacy of initial versus sequential combination of denosumab and teriparatide in osteoporosis at high fracture risk.

This study compared 12-month effects of an initial combination versus a sequential combination strategy of denosumab and teriparatide in osteoporosis patients at high fracture risk, including those already receiving denosumab. It found differential efficacy, with limited spinal benefit and a clinically important risk of hip bone loss when teriparatide is added after denosumab, supporting a site-specific risk–benefit assessment. The results are significant because they inform optimal sequencing of denosumab and teriparatide to maximize bone mineral density gains while minimizing skeletal harm.

Li XP, Chen R, Cheng C et al. · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · (2026) · View on PubMed ↗

Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial.

This 52-week randomized placebo-controlled trial studied subcutaneous semaglutide 1 mg once weekly versus placebo in 106 adults with type 2 diabetes and chronic kidney disease, using integrated multiparametric kidney MRI, kidney biopsy histology, and single-nucleus plus spatial transcriptomics. Semaglutide preserved kidney function and the multi-omics analyses were used to identify kidney-specific mechanisms of action. The results are significant because they link a GLP-1 receptor agonist’s renal benefit to mechanistic pathways that could inform future kidney-protective therapies in type 2 diabetes.

Tuttle KR, Bjornstad P, Smith C et al. · Nature medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Sex- and fiber type-specific remodeling of the muscle proteome implicates CSRP3 in resistance training-induced hypertrophy.

This study analyzed sex- and fiber type-specific remodeling of the human skeletal muscle proteome after 8 weeks of resistance training. It found that type II fibers showed greater adaptations across sexes, females had greater remodeling of intermediate filaments, and among proteins upregulated in type II fibers, CSRP3 overexpression promoted muscle hypertrophy and implicated CSRP3 in resistance training–induced growth. The significance is identifying CSRP3 as a candidate molecular driver of hypertrophy with sex- and fiber-type context, which could guide precision approaches to training or therapeutics.

Moesgaard L, Moreno-Justicia R, Schmalbruch J et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

---

Clinical Decision Tools, Guidelines & Patient Communication

Assessment of the Sustained Response to Systemic Treatment for Atopic Dermatitis in Patients Who Achieved Disease Remission: A Systematic Review and Network Meta-Analysis Comparing Withdrawal, Dose Reduction and Dosing Interval Extension Versus Continuation Therapy.

This systematic review and network meta-analysis compared systemic atopic dermatitis (AD) management strategies—withdrawal, dose reduction, or dosing interval extension—versus continuation therapy in patients who achieved disease remission. The analysis synthesized comparative effectiveness across studies to identify which de-escalation approach best sustained remission. Clinically, the results inform step-down decision-making for systemic AD therapy to maintain remission while potentially reducing drug exposure.

Nakano J, Barroso LF, de Carvalho Mesquita K et al. · The British journal of dermatology · (2026) · View on PubMed ↗ · Free PDF ↗

Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.

This narrative review synthesized mechanism-based and emerging therapeutic strategies for inflammatory bowel disease (IBD), focusing on positioning of newer drug classes such as selective IL-23 inhibitors, Janus kinase (JAK) inhibitors, and sphingosine-1-phosphate receptor modulators. The key message was that treatment algorithms are increasingly complex and should be guided by mechanisms of action, disease modification goals, and management of refractory disease beyond prior “therapeutic ceiling” concepts. The review is clinically significant because it provides a framework for selecting and sequencing therapies to improve outcomes in patients who do not respond to standard approaches.

Subhaharan D, Subramanian S · Alimentary pharmacology & therapeutics · (2026) · View on PubMed ↗

Early multimodal vasopressor strategy in septic shock: results of the TRICYCLE randomized controlled trial.

The TRICYCLE randomized controlled trial studied whether an early multimodal vasopressor strategy using angiotensin II, vasopressin, and norepinephrine improves physiological and clinical outcomes in patients with septic shock. Compared with standard care, early initiation of multiple vasopressors aimed to more effectively counteract septic-shock vasodilation through complementary mechanisms. If supported by the trial results, this approach could change critical-care practice by optimizing timing and combination of vasopressors to improve survival and organ-support outcomes.

Kalamar Ž, Landoni G, Gorenjak M et al. · Critical care (London, England) · (2026) · View on PubMed ↗ · Free PDF ↗

Tonicity drives collecting duct maturation in the mammalian kidney.

This study developed and applied uRARE-seq (urine random priming and affinity capture of cell-free RNA fragments for sequencing) to profile urine cfRNA in 683 patients with prostate, kidney, or bladder cancer and controls. uRARE-seq detected localized bladder cancer with 95% sensitivity at 90% specificity and outperformed urine tumor DNA analysis, with tumor-derived transcript signals from genitourinary tissues and robustness to the factors tested (details truncated). Clinically, this supports a noninvasive urine liquid-biopsy approach for bladder cancer detection and treatment-response prediction using cfRNA rather than DNA.

Inoue D, Miike K, Tanigawa S et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Insights into the microcirculation in pediatric chronic spontaneous urticaria: A nailfold videocapillaroscopy study.

This cross-sectional study used standardized nailfold videocapillaroscopy (NVC) to assess microvascular alterations in 41 pediatric patients with chronic spontaneous urticaria (CSU) and related findings to disease activity, control, autoreactivity, and inflammatory markers. It demonstrated pediatric systemic microvascular involvement consistent with endothelial participation beyond the skin, with capillaroscopic measures associated with CSU clinical/immunologic features (specific results truncated). These findings extend adult observations to children and suggest NVC biomarkers may help characterize systemic inflammation in pediatric CSU.

Karakurt LT, Küçük E, Kacar D et al. · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · (2026) · View on PubMed ↗

ESCAPE enables receptor-specific chemogenetic dissection of GPCR signaling.

The study developed ESCAPE, an off-target-free chemogenetic platform, and demonstrated its use to dissect physiological signaling of the adenosine A2A receptor (A2AR), a GPCR implicated in neurodegenerative diseases. By leveraging A2AR ligand recognition and pairing a clinically validated A2AR antagonist with an engineered A2A component (details truncated), the approach enables receptor-specific GPCR signaling interrogation while minimizing pharmacologic off-target effects. This provides a more precise tool for mapping GPCR function in vivo and could improve target validation for GPCR-directed therapies.

Matsuoka Y, Inoue H, Hori T et al. · Cell chemical biology · (2026) · View on PubMed ↗

An Electronic Frailty Index Is Associated with Outcomes in Older Adults Receiving CAR-T Therapy.

The study retrospectively analyzed older adults (age ≥65) with multiple myeloma or B-cell non-Hodgkin lymphoma receiving commercial CAR-T therapy to determine whether an electronic frailty index (eFI) predicts outcomes. Higher eFI categories (frail/very frail vs robust/prefrail) were associated with worse overall survival (OS) and event-free survival (EFS) and with greater toxicity (toxicity details truncated). Clinically, it supports using routinely derived eFI to risk-stratify older CAR-T candidates and guide treatment planning.

Enns JP, Korst MR, Horick N et al. · Blood advances · (2026) · View on PubMed ↗ · Free PDF ↗

Markers of cervical intraepithelial neoplasia grade 2 regression and subsequent risk of CIN3.

The study used electronic medical records from 5,938 women with newly detected CIN2 managed with delayed treatment at Kaiser Permanente Northern California to quantify regression markers and predict subsequent CIN3+ risk. Histologic regression within 1 year was common but still carried appreciable CIN3+ risk, whereas HPV-negative results were associated with lower subsequent CIN3+ risk than HPV-positive outcomes (other marker details truncated). This refines prognostic counseling for CIN2 by identifying which regression markers—especially HPV status—better predict progression risk.

Cheung LC, Mao F, Rydzak G et al. · Journal of the National Cancer Institute · (2026) · View on PubMed ↗

Structural and kinetic mechanisms of state-dependent potassium channel inhibition.

This study investigated state-dependent inhibition of the cardiac KCNQ1 (Kv7.1) potassium channel by the inhibitor UCL2077 using cryo-EM structures and molecular dynamics (MD) simulations in two activation states. It found that UCL2077 binds in pockets formed by S5–S6 helices and adjacent protomer S6, breaks tetrameric symmetry, and preferentially stabilizes intermediate over activated channel states. Scientifically, these structural/kinetic insights explain how state-dependent binding translates into altered drug potency, informing rational design of antiarrhythmic KCNQ1 modulators.

Kyriakis E, Roscioni A, Eldstrom J et al. · Science advances · (2026) · View on PubMed ↗ · Free PDF ↗

Creatine supplementation in soccer players: a systematic review.

This systematic review studied whether creatine supplementation improves performance, body composition, and recovery/fatigue-related outcomes in soccer players. It synthesized evidence from PubMed, Scopus, and Web of Science to address soccer-specific, high-intensity intermittent demands where rapid ATP resynthesis is critical, aiming to resolve inconsistencies across prior smaller studies. The significance is that it provides an evidence-based assessment to guide sports nutrition decisions for soccer athletes regarding creatine as an ergogenic aid.

Ashtary-Larky D, Candow DG, Antonio J et al. · Journal of the International Society of Sports Nutrition · (2026) · View on PubMed ↗ · Free PDF ↗

Resistant Hypertension: State of the Art Review.

This state-of-the-art review examined resistant hypertension in adults with blood pressure above target despite at least three antihypertensive drugs (including a diuretic) or controlled blood pressure requiring four or more medications, emphasizing the need to distinguish true resistance from apparent resistance. It highlights that pseudo-resistance—driven by inaccurate office blood pressure measurement, medication nonadherence, or white-coat effect—must be excluded, and that ambulatory and home blood pressure monitoring are central to confirming true resistant hypertension. Clinically, this approach improves risk stratification for heart failure, stroke, and chronic kidney disease progression and guides more accurate treatment escalation.

Khan MS, Arshad MS, Hall ME et al. · Clinical journal of the American Society of Nephrology : CJASN · (2026) · View on PubMed ↗

Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

This ADA/EASD consensus report updated management recommendations for type 2 diabetes in non-pregnant adults, based on a systematic review of evidence published since 2022. It emphasizes a shift from focusing only on hyperglycemia to holistic management of type 2 diabetes and multiple long-term conditions, alongside core lifestyle and diabetes-care fundamentals. Clinically, the updated guidance supports more comprehensive, evidence-based care planning across the U.S. and Europe.

Davies MJ, Aroda VR, Bajaj M et al. · Diabetologia · (2026) · View on PubMed ↗ · Free PDF ↗

Clinical spectrum and genetic landscape of MTHFR deficiency: a cohort study including novel variants.

This multicenter retrospective cohort study characterized the clinical presentation, biochemical profile, and molecular spectrum of methylene tetrahydrofolate reductase (MTHFR) deficiency in 19 patients from 10 metabolic disease centers, including 13 with early-onset disease. The key finding was a detailed description of the genotype–phenotype landscape, including identification of novel MTHFR variants and associated neurodevelopmental delay patterns in early-onset cases. Scientifically, this expands the known genetic and clinical spectrum of MTHFR deficiency and can improve diagnostic yield and prognostic counseling.

Karalar Pekuz OK, Teke Kisa P, Yildiz S et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · (2026) · View on PubMed ↗

Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

This ADA/EASD consensus report updated recommendations for management of type 2 diabetes in nonpregnant adults, using a systematic review of publications since the 2022 update. It broadens the focus from glycemic control to holistic management of type 2 diabetes and its associated long-term conditions, while reinforcing lifestyle and foundational care elements for multidisciplinary teams in the U.S. and Europe. Clinically, it provides an updated framework for treatment selection and comprehensive risk reduction.

Davies MJ, Aroda VR, Bajaj M et al. · Diabetes care · (2026) · View on PubMed ↗ · Free PDF ↗

Dynamic prediction of the development of extrahepatic organ failures in ICU patients with decompensated cirrhosis.

This study developed and externally validated a dynamic artificial intelligence (AI) framework to predict extrahepatic organ failure (EOF) in adult ICU patients with decompensated cirrhosis, aiming to forecast whether patients would develop ≥2 EOF 12 hours later. Using MIMIC-IV for derivation and eICU-CRD for external validation, it addressed the limitation of traditional static prognostic tools by modeling rapidly changing physiology in critical illness. Clinically, a real-time dynamic prediction tool could improve timing of interventions and short-term mortality risk management in this high-risk population.

Yeo YH, Que L, Zhang M et al. · eGastroenterology · (2026) · View on PubMed ↗ · Free PDF ↗

Life-Threatening Eosinophilic Granulomatosis With Polyangiitis During Omalizumab Therapy for Chronic Urticaria: Missed Diagnosis, Induction, or Unmasking?

This case report studied eosinophilic granulomatosis with polyangiitis (EGPA) in a 67-year-old woman with chronic urticaria and late-onset asthma who was receiving omalizumab. The patient developed life-threatening EGPA manifestations (including dyspnea, epistaxis, and hemoptysis) with eosinophilia and elevated inflammatory markers during omalizumab therapy. Clinically, the report highlights the need to consider EGPA when severe eosinophilic disease emerges during biologic treatment for chronic urticaria, to avoid missed diagnosis or delayed induction of appropriate vasculitis therapy.

Zymaris P, Georgopoulou A, Tzioutzia A et al. · Cureus · (2026) · View on PubMed ↗ · Free PDF ↗

Effects of caffeine supplementation on post-exercise recovery: a systematic review and three-level meta-analysis of perceptual, functional performance, physiological, and sleep outcomes.

This systematic review and three-level meta-analysis evaluated randomized controlled trials of caffeine supplementation versus placebo or caffeine-free conditions on post-exercise recovery outcomes in humans. Across studies, caffeine’s effects were synthesized for perceptual recovery, functional performance, physiological recovery, and sleep recovery, with moderators explored using three-level random-effects models. Scientifically, the work provides an evidence-based synthesis of how caffeine may influence recovery after exercise and identifies factors that could explain heterogeneity across trials.

Zhang J, Li Y, Wei B et al. · Frontiers in physiology · (2026) · View on PubMed ↗ · Free PDF ↗

Consensus Guidelines for Diagnosis and Management of Pyruvate Dehydrogenase Complex Deficiency.

This consensus guideline article studied diagnosis and management of primary pyruvate dehydrogenase complex deficiency (PDCD), a monogenic disorder caused by pathogenic variants in genes encoding pyruvate dehydrogenase complex subunits or regulatory components. It found that PDCD presents across a spectrum from early congenital lactic acidosis to childhood-onset developmental delay with epilepsy and adult-onset neurological phenotypes, with substantial international variability in management. The guideline’s significance is that it standardizes emergency and outpatient diagnostic and treatment approaches for PDCD to reduce care variability and improve outcomes.

Keshavan N, Neugebauer J, Bellusci M et al. · Journal of inherited metabolic disease · (2026) · View on PubMed ↗ · Free PDF ↗

RETRACTED: Sydykov et al. Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice. Int. J. Mol. Sci. 2020, 21, 9099.

This article was retracted and therefore did not provide valid scientific findings regarding genetic deficiency and pharmacological stabilization of mast cells in a mouse model of pressure overload-induced right ventricular remodeling. The journal retraction indicates the underlying study results should not be considered reliable. Scientifically, the retraction serves as a correction to the literature and prevents downstream clinical or mechanistic conclusions based on the flawed work.

Sydykov A, Luitel H, Mamazhakypov A et al. · International journal of molecular sciences · (2026) · View on PubMed ↗ · Free PDF ↗

Safety and functional efficacy of transperineal laser ablation in large prostates (>80 mL): a prospective single-center study.

This prospective single-center study evaluated the safety and functional efficacy of transperineal laser ablation (TPLA) in men with large prostates (>80 mL), enrolling 85 patients. It found that TPLA performed under local anesthesia with transrectal ultrasound guidance was feasible and assessed perioperative and catheter-related outcomes along with mid-term efficacy measures. Clinically, the study supports the use of TPLA as a minimally invasive option for very large prostates while providing outcome data relevant to procedure safety and functional recovery.

Conte FL, Saladino M, Lambertini L et al. · Minerva urology and nephrology · (2026) · View on PubMed ↗

Global guidelines for the management of penile cancer: evaluating clinical alignment and methodological rigor.

This review studied how well major international penile cancer guidelines align and how rigorously they are developed, comparing EAU-ASCO (2025), NCCN (2025), and ESMO (2024). It found that the guidelines differ in recommendations across primary tumor management, lymph node strategies, systemic therapy, and follow-up, and the authors assessed methodological quality alongside clinical content. The significance is that it helps clinicians and guideline developers understand where recommendations are consistent versus divergent and where methodological improvements may be needed.

Pandolfo SD, Aveta A, Iossa V et al. · Minerva urology and nephrology · (2026) · View on PubMed ↗

Association between the cumulative average triglyceride-glucose-waist circumference index and new-onset hypertension among Chinese middle-aged and older adults-a national prospective study.

This national prospective study assessed whether cumulative average triglyceride–glucose–waist circumference index (TyG-WC) predicts new-onset hypertension among Chinese middle-aged and older adults. Higher cumulative average TyG-WC was associated with increased risk of developing hypertension, supporting TyG-WC as a practical surrogate for insulin resistance and central adiposity-related metabolic risk. Clinically, TyG-WC could enable low-cost identification of individuals at elevated hypertension risk in community settings.

Kuang Z, Zhang B, Lin S et al. · Cardiovascular diabetology. Endocrinology reports · (2026) · View on PubMed ↗ · Free PDF ↗

Migraine 1-2-3-4-5: a candidate communication aid for adult migraine without aura.

This correspondence proposed “Migraine 1-2-3-4-5,” a communication aid for adults (≥18 years) with recurrent migraine without aura based on ICHD-3 clinical features. The tool converts key positive migraine history elements (associated symptoms, headache features, duration, and attack frequency) into five numerical anchors to standardize patient–clinician discussion. If adopted, it may improve recognition and documentation of migraine phenotypes in routine care and research.

Zhang Y, Guo Z, Lin C et al. · The journal of headache and pain · (2026) · View on PubMed ↗ · Free PDF ↗

Neuropsychiatric outcomes after montelukast versus inhaled corticosteroids in pediatric asthma: a pooled birth cohort study.

This pooled birth cohort analysis compared neuropsychiatric outcomes after montelukast versus inhaled corticosteroids (ICS) in children with asthma, using the AM-PREGNANT cohort (US) and the Quebec Pregnancy Cohort (Canada). Children whose initial controller therapy was montelukast monotherapy were evaluated for risk of neuropsychiatric events relative to those receiving ICS monotherapy. The results aim to clarify the safety signal for montelukast-associated neuropsychiatric adverse events in pediatric asthma using large, population-based cohorts.

Jiao XF, Ducharme FM, Leal LF et al. · BMC medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Beyond correlation and causation: epistemic caution, anomalous findings, and COVID-19 vaccine safety.

This article is a conceptual analysis of epistemic reasoning in COVID-19 vaccine safety, focusing on when “correlation does not imply causation” should prompt caution versus when it may prematurely stop investigation of adverse events. It argues that epistemic caution can contribute to “premature epistemic closure” if lack of established causality is treated as sufficient to avoid further study. The significance is improved scientific and ethical frameworks for evaluating vaccine safety signals without either overclaiming causality or under-investigating potential harms.

Siebner AS, Rubio-Casillas A, Raszek M et al. · Philosophy, ethics, and humanities in medicine : PEHM · (2026) · View on PubMed ↗ · Free PDF ↗

Rehabilitation of Athletes With Hamstring Strain Injury: SONAFE-Brazil Clinical Practice Guideline.

This SONAFE-Brazil clinical practice guideline studied which physical-therapy interventions improve rehabilitation outcomes for athletes with hamstring strain injury, using evidence from randomized clinical trials. It applies the GRADE framework to synthesize and update targeted recommendations for clinician decision-making during hamstring-strain rehab. The guideline is significant because it standardizes evidence-based sports physical therapy strategies for a common athletic injury in Brazil.

Baroni BM, Ribeiro de Oliveira R, Pereira ALA et al. · The Journal of orthopaedic and sports physical therapy · (2026) · View on PubMed ↗

Universal versus Guideline-Directed Germline Testing in Breast Cancer: Incremental Diagnostic Yield in a Predominantly Black Population.

This retrospective study compared universal germline testing (UT) versus National Comprehensive Cancer Network (NCCN)-guided guideline-directed testing in female breast cancer patients without prior germline testing in a predominantly Black population. It evaluated incremental diagnostic yield by measuring testing uptake and the rate of pathogenic/likely pathogenic findings between strategies. The findings are significant because they address whether universal germline testing reduces missed mutation carriers compared with guideline-based criteria in an underrepresented population.

Velazquez K, Jeng A, Roudakova K et al. · Annals of surgical oncology · (2026) · View on PubMed ↗

Value-based neonatology (VBN): a new ethical paradigm for newborn care.

This review examined ethical considerations for newborn care and proposes “Value-Based Neonatology” in the context of the Lancet Commission on the Future of Neonatology. It argues that neonatal research and clinical priorities should be guided by a value-based framework that addresses overlooked ethical issues across stakeholders rather than focusing only on traditional “curing” paradigms. The proposed approach is significant because it could reshape neonatal policy, research agendas, and resource allocation to better align outcomes with patient- and society-relevant values.

Di Pietro ML, De Luca D · European journal of pediatrics · (2026) · View on PubMed ↗

Surgical steps and relevant anatomical landmarks for the implantation of an inflatable penile prosthesis reservoir placed in the retropubic and submuscular abdominal (“ectopic”) space.

This educational/anatomical study evaluated a postgraduate masterclass program for inflatable penile prosthesis implantation, focusing on reservoir placement in the retropubic and submuscular abdominal “ectopic” space. It described step-by-step surgical training using predissected anatomical specimens and tutored procedures in body donors to teach relevant anatomical landmarks and operative steps. The significance is improved surgical standardization and training for a technically challenging component of penile prosthesis surgery.

Osmonov D, Heinze T, Wilson SK et al. · International journal of impotence research · (2026) · View on PubMed ↗

---

Regenerative Medicine & Hormone Replacement

Functional analysis of adrenocorticotropic-hormone-producing pituitary cells derived from human pluripotent stem cells in murine and primate models of hypopituitarism.

This work performed functional analyses of adrenocorticotropic-hormone (ACTH)-producing pituitary cells derived from human pluripotent stem cells in murine and primate hypopituitarism models. The study tested whether these stem-cell-derived ACTH cells can function in vivo to address ACTH deficiency and related adrenal insufficiency. Scientifically, it advances regenerative approaches for precisely regulated hormone replacement in hypopituitarism, potentially reducing risks from inadequate dosing and circadian/stress mismatches.

Kondo T, Suga H, Watari K et al. · Stem cell research & therapy · (2026) · View on PubMed ↗ · Free PDF ↗

Reactivation of the embryonic ζ-globin gene ameliorates severe forms of α-thalassemia.

This study investigated whether reactivating the embryonic ζ-globin gene can treat severe α-thalassemia, including severe hemoglobin H (HbH) disease and surviving individuals with Hb Bart’s hydrops fetalis syndrome. The authors identified cis-regulatory elements controlling ζ-globin silencing in definitive erythroid cells and developed gene-editing strategies that reactivate ζ-globin expression to therapeutically relevant levels. The work is significant because it provides a targeted gene-regulatory approach that could reduce transfusion dependence or the need for stem cell transplantation in severe α-thalassemia.

Liu S, Ejaz A, King AJ et al. · Nature genetics · (2026) · View on PubMed ↗ · Free PDF ↗

A human-induced pluripotent stem cell-derived spheroid model to investigate myelin injury and repair.

This research developed a human induced pluripotent stem cell (iPSC)-derived spheroid model enriched with mature myelinating oligodendrocytes and functionally reactive microglia to study demyelination and remyelination. The model recapitulated myelin fragmentation, microglial reactivity and phagocytosis of myelin debris, oligodendrocyte generation/differentiation, and axonal ensheathment with newly formed myelin after a demyelinating insult. The platform is significant because it offers a reproducible human CNS system to test and discover therapies that promote remyelination.

Ramesan S, Mason J, Kumar SS et al. · Nature neuroscience · (2026) · View on PubMed ↗ · Free PDF ↗

---

Cancer Genomics, Epigenetics & 3D Genome Architecture

Single-molecule chromatin tracing reveals a diversity of megabase heterochromatin domains.

This study used single-molecule chromatin tracing in Caenorhabditis elegans to map nascent megabase-scale heterochromatin domain classes and their dependence on condensin I. It identified three domain types: sharp-boundary condensin I-dependent TAD-like domains (TADLs) arising before zygotic genome activation, similarly sized condensin-independent elCIDs (including one spanning the 5S-spliced leader repeat locus), and a third “decomp” class (details truncated in the abstract). These sequence-level domain classes refine how heterochromatin is organized and regulated during early development, linking condensin activity and 3D genome architecture to transcriptional timing.

Pulido-Barrera DC, You JE, Angonezi AL et al. · Nature structural & molecular biology · (2026) · View on PubMed ↗ · Free PDF ↗

An epigenetic program dictates MYC amplification dynamics that promote transient, extrachromosomal, and inherited genomic events.

The study investigated in cancer models how epigenetic enzymes control MYC amplification dynamics, focusing on focal over-replication that generates extrachromosomal DNA (ecDNA) and can be inherited. H3K4 methylation primes MYC for amplification via recruitment of the KDM4C demethylase, whereas SETD2-mediated H3K36 trimethylation restrains copy gains; SETD2 loss or inhibition increases recruitment of catalytically active KDM4C to drive stepwise MYC copy gains, and TP53 loss or apoptosis suppression accelerates higher-level amplification emergence. These findings identify specific chromatin regulators (SETD2, KDM4C, H3K4/H3K36 marks) as drivers of ecDNA formation and inherited genomic events, informing epigenetic strategies to limit MYC-driven tumor evolution.

Ferman BI, Azadegan C, Santoro J et al. · Molecular cell · (2026) · View on PubMed ↗ · Free PDF ↗

Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort.

The study analyzed in a Japanese nationwide real-world cohort from the Center for Cancer Genomics and Advanced Therapeutics database the molecular characteristics and clinical outcomes of non-small cell lung cancer (NSCLC) patients with ERBB2-activating mutation-positive tumors. It focused on the heterogeneous spectrum of ERBB2 variant subtypes and aimed to relate individual variant clinicogenomic features to patient outcomes (results truncated). This helps clarify which ERBB2 mutation subtypes carry distinct prognostic/clinical implications, supporting more precise genomic stratification in routine practice.

Yamashita M, Ninomiya K, Tomida S et al. · European journal of cancer (Oxford, England : 1990) · (2026) · View on PubMed ↗ · Free PDF ↗

Placenta-Related PEG10 Inhibits mRNA Decay to Promote Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.

This Cancer Research study investigated the placenta-related gene PEG10 in hepatocellular carcinoma (HCC), focusing on how it affects mRNA decay and glucose metabolism to drive tumor progression. It found that PEG10 (a paternally expressed retrovirus-like gene) is overexpressed in HCC, correlates with poor prognosis, and that liver-specific deletion of Peg10 significantly impedes hepatocarcinogenesis and tumor progression. The significance is identification of PEG10 as a mechanistic regulator of mRNA stability and metabolic reprogramming, suggesting a potential therapeutic target in HCC.

Yao X, Wu B, Yang C et al. · Cancer research · (2026) · View on PubMed ↗

A DNA G-Quadruplex-Targeting Ligand Suppresses c-MYC Expression: Implications for Gemcitabine‑Resistant Pancreatic Cancer.

This preclinical study evaluated a DNA G-quadruplex-targeting ligand strategy to suppress c-MYC expression in pancreatic cancer, focusing on gemcitabine-resistant models. It found that the styryl quinolinium ligand PQB-4 selectively binds c-MYC DNA G-quadruplex structures (KD < 1.0 µM) and suppresses c-MYC transcription, producing antiproliferative effects in pancreatic cancer cell lines including gemcitabine-resistant contexts. The scientific significance is that stabilizing c-MYC promoter G-quadruplexes may provide a potential therapeutic approach for pancreatic cancer that resists gemcitabine.

Zheng BX, Wang YK, Chen ZX et al. · Angewandte Chemie (International ed. in English) · (2026) · View on PubMed ↗ · Free PDF ↗

BRIP1, a G-quadruplex DNA helicase, protects against AID-induced genomic instability by limiting R-loop accumulation.

This study investigated how the DNA helicase BRIP1 (FANCJ) protects against activation-induced cytidine deaminase (AID)-induced genomic instability by limiting R-loop accumulation. Using BRIP1 biology in the context of AID-driven mutagenesis and non-B DNA structures such as G-quadruplexes, the authors tested the mechanistic role of BRIP1 in preventing R-loop–associated damage. These findings highlight BRIP1 as a key genome-stability factor relevant to B-cell lymphoma risk driven by AID mis-targeting.

Mahboob A, Ahmad H, Fatma N et al. · Molecular medicine (Cambridge, Mass.) · (2026) · View on PubMed ↗ · Free PDF ↗

Immunohistochemical profile of molecularly verified clear cell renal cell carcinomas.

This study investigated the immunohistochemical (IHC) profiles of molecularly verified clear cell renal cell carcinomas (ccRCC) and correlated them with architectural patterns and key driver alterations. Using next-generation sequencing (NGS)–verified ccRCC cases from 2015–2024, the authors found that IHC staining patterns can be aberrant and may confound diagnosis, with associations to molecular and morphological features. The work is significant because it improves diagnostic reliability and links IHC behavior to underlying driver biology in ccRCC.

Tanaka KS, Zhang L, Ding CC et al. · Histopathology · (2026) · View on PubMed ↗

Alterations in 3D-DNA architecture drive unique leukemic profiles in IDH1- and DNMT3A-mutant acute myeloid leukemia.

This study examined how alterations in 3D-DNA architecture drive distinct leukemic profiles in acute myeloid leukemia (AML) with IDH1 and DNMT3A mutations. Using cellular models carrying IDH1 p.R132H or DNMT3A p.R882H and primary AML samples, the authors assessed genome-wide 3D-DNA conformational changes to identify how these structural shifts influence oncogenic signaling and reveal therapeutic vulnerabilities. The work is significant because it links mutation-specific genome organization to leukemic behavior and may guide new vulnerability-targeted therapies in genetically defined AML.

Steinhäuser S, Sreenivasan VKA, Baden D et al. · Leukemia · (2026) · View on PubMed ↗ · Free PDF ↗

---

Immunotherapy, Tumor Microenvironment & CAR-T

Multi-omics-driven personalized management of advanced HCC.

The study used tumor specimens from a prospective clinical trial of transarterial chemoembolization (TACE) plus immune checkpoint blockade (ICB) to perform multi-omics profiling (spatial proteomics/transcriptomics, single-cell RNA-seq, and bulk transcriptomics) in advanced hepatocellular carcinoma (HCC). Treatment response correlated with enrichment of anti-tumor T cell regions driven by cGAS–STING activation in immune-suppressive epithelial cells, while fibrotic processes impeded these pro-response programs. Clinically, this provides a multi-omics framework to stratify advanced HCC patients by cGAS–STING–linked immune activation and fibrosis-associated resistance.

Sheng J, Song J, Wang L et al. · Cell reports. Medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Chemotherapy enhances cancer vaccine efficacy and expands stem-like TCF1+CD8+ T cells.

The study evaluated in preclinical/experimental settings whether chemotherapy synergizes with heterologous prime–boost viral vector cancer vaccines and assessed effects on T cell populations. Carboplatin plus paclitaxel (CarboTaxol) and cyclophosphamide improved vaccine efficacy and increased antigen-specific CD8+ T cell responses, acting as immunological adjuvants even without tumor presence; CarboTaxol induced early antigen-independent expansion of stem-like TCF1+ CD8+ T cells. This supports combining specific chemotherapies with cancer vaccines to boost durable, stem-like anti-tumor immunity.

Noblecourt L, Wicki A, Jainarayanan A et al. · Cancer cell · (2026) · View on PubMed ↗ · Free PDF ↗

Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

The study retrospectively assessed medium-term neurocognitive outcomes in patients with isolated CNS lymphomas treated with CAR T-cell therapy at Pitié-Salpêtrière Hospital (June 2021–April 2024). Using routine neuropsychological testing across cognitive domains (language, memory, executive function, visuospatial abilities, and overall functioning), the authors evaluated how cognition evolved beyond the short-term post-treatment period (specific findings truncated). This is clinically important for counseling CNS lymphoma patients receiving CAR-T therapy and for planning longer-term cognitive monitoring and supportive care.

Mersali S, Chapelle R, Ribeiro M et al. · Neurology · (2026) · View on PubMed ↗

Tumor cell-intrinsic stress states drive sensitivity to CAR T cell therapy in pancreatic cancer.

This work studied tumor-intrinsic stress states that determine sensitivity to chimeric antigen receptor (CAR) T cell therapy in pancreatic ductal adenocarcinoma (PDAC) using modular in vivo CRISPR screens, single-cell genomics, and immunocompetent orthotopic mouse models. It found that oxidative and proteotoxic stress pathways modulate CAR T response, and disrupting stress regulatory genes—especially Keap1 and Slc33a1—sensitized PDAC tumors to CAR T killing in vivo, with Nrf2 pathway hyperactivation implicated. The significance is mechanistic identification of actionable tumor stress regulators that could be leveraged to improve CAR T efficacy in solid tumors like PDAC.

Fröse J, Chen E, Whittaker CA et al. · Science advances · (2026) · View on PubMed ↗ · Free PDF ↗

PAK4 exacerbates melanoma immunosuppression by promoting exosome release.

This PNAS study examined how PAK4 promotes melanoma immunosuppression by regulating tumor exosome release, linking clinical observations of PAK4 expression with mechanistic cell biology. It found that PAK4 phosphorylates Annexin-A2 (ANXA2) at Ser26 to drive nuclear-to-cytoplasmic translocation, enabling S100A10–ANXA2 heterotetramer formation that promotes multivesicular body docking to the plasma membrane and increases immunosuppressive exosome output. The significance is that PAK4–ANXA2 signaling may be a therapeutic target to reduce exosome-mediated immune suppression and potentially improve responses to anti–PD-1 therapy in melanoma.

Zhou R, Xu T, Shen Z et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗ · Free PDF ↗

Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance.

This cancer research study investigated how resistance emerges to KRAS inhibition in pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) models, using transcriptomic and proteomic analyses to compare sensitive versus resistant states. It found that even when mutant KRAS signaling is suppressed, resistant cells sustain cell-cycle progression by engaging distinct, context-dependent orthogonal mitogenic pathways, which can be broadly targeted with the pan-RAS-ON inhibitor RMC-6236 but still allow acquired resistance. Scientifically, the work identifies actionable cell-cycle bypass mechanisms that could inform combination strategies to overcome KRAS inhibitor resistance.

Kumarasamy V, Wang J, Yau EH et al. · Cancer research · (2026) · View on PubMed ↗

Spatial multi‑omics identifies an SPP1+ macrophage‑driven anti‑apoptotic niche in osteoarthritis synovium via the SPP1‑CD44 axis.

This study integrated spatial transcriptomics with single-cell RNA sequencing and in vitro apoptotic assays to define macrophage subsets and spatial niches in osteoarthritis (OA) synovium, focusing on an SPP1+ macrophage-driven anti-apoptotic niche. It found that SPP1+ macrophages promote apoptosis evasion via an SPP1–CD44 axis, and this was functionally supported in a mouse OA model using adeno-associated virus–mediated macrophage-targeted SPP1 knockdown and CCL3 neutralization. The findings are significant because they pinpoint a spatially organized macrophage pathway that could be targeted to reduce chronic synovitis and OA progression.

Gong H, Shen H, Zhang F et al. · International journal of molecular medicine · (2026) · View on PubMed ↗ · Free PDF ↗

OX40 Ligand/OX40 Axis as the Inflammatory Prequel in Atopic Dermatitis: A Narrative Review.

This narrative review studied the OX40 ligand (OX40L)/OX40 costimulatory axis in the immune activation cascade of atopic dermatitis, focusing on antigen-presenting cell–T cell signaling. It reports that OX40L/OX40 signaling is active during a dynamic inflammatory phase of atopic dermatitis and may contribute to disease persistence and heterogeneity. The review is clinically significant because it highlights a multi-pathway immune target that could inform next-generation therapies for moderate-to-severe atopic dermatitis.

Kwatra SG, Guttman-Yassky E, Oppenheimer J et al. · Dermatology and therapy · (2026) · View on PubMed ↗ · Free PDF ↗

Senolytics dasatinib and quercetin in metabolic dysfunction-associated steatohepatitis: a proof-of-principle randomized, controlled trial.

This phase 2, double-blind, randomized, placebo-controlled trial studied intermittent senolytic therapy with dasatinib plus quercetin (D+Q) in participants with fibrotic metabolic dysfunction–associated steatohepatitis (MASH). Thirty-one participants received dasatinib 100 mg/day plus quercetin 1,000 mg/day for three consecutive days per week over 3 weeks (repeated as per protocol) versus placebo, testing whether senescence targeting improves disease outcomes. The trial is significant because it provides human proof-of-principle for senolytics as a therapeutic strategy in fibrotic MASH.

Koning M, Kovynev A, Fondevila MF et al. · Nature metabolism · (2026) · View on PubMed ↗ · Free PDF ↗

SLC4A7/NBCn1 maintains intracellular pH to support mTORC1 activity and antibody-secreting cell differentiation.

This mechanistic study investigated how the Na+/HCO3− cotransporter SLC4A7/NBCn1 regulates intracellular pH to support mTORC1 activity and antibody-secreting cell differentiation. It found that SLC4A7 deletion impairs plasmablast/plasma cell differentiation and antibody responses in mice after immunization and influenza A infection, associated with intracellular acidification and lysosomal alkalinization. The significance is that SLC4A7/NBCn1 emerges as a pH–mTORC1 axis regulator that could be targeted to modulate humoral immunity and vaccine/autoimmune responses.

Hu K, Wang YH, Tao AY et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

---

Microbiome, Microbial Interactions & Infectious Ecology

A dual-action bacteriophage protein Ped1 degrades DNA and blocks replication in Pseudomonas aeruginosa.

This mechanistic study characterized Ped1, a dual-action bacteriophage protein from Pseudomonas aeruginosa phage PaoP5, in the context of phage therapy. Using structural and biochemical approaches including a 2.3-Å crystal structure, the authors showed Ped1 is an α/β-nuclease that degrades both double- and single-stranded DNA and directly inhibits the host replication machinery, suppressing bacterial growth. The work is clinically relevant because it clarifies a concrete anti-bacterial mechanism that could inform engineering or selection of phage-derived therapeutics against antimicrobial-resistant P. aeruginosa.

Wang T, Yan W, Wang C et al. · The EMBO journal · (2026) · View on PubMed ↗ · Free PDF ↗

A conserved GTPase complex gates exocytosis for defence and parasitism across alveolates.

This study identified and characterized a conserved GTPase complex (Nd-GTPase-Nd9-NdP1) that gates organelle exocytosis for defence and parasitism across alveolates. Using comparative models in Tetrahymena thermophila and Toxoplasma gondii with functional genetics, cryo-electron tomography, and integrative structural modeling, the authors showed the complex is required for regulated secretion in these organisms. Scientifically, this reveals a conserved secretion mechanism outside metazoans and may provide targets for controlling parasite invasion or enhancing defence-related exocytosis.

Cova MM, Morley L, Maynadier M et al. · Nature microbiology · (2026) · View on PubMed ↗ · Free PDF ↗

Fungus Rhizopus arrhizus promotes MASLD-associated hepatocellular carcinoma through generating kynurenic acid.

The study tested in mouse models and human MASLD-associated hepatocellular carcinoma (MASLD-HCC) cells whether the gut fungus Rhizopus arrhizus promotes tumorigenesis and identified the responsible metabolite. R. arrhizus was enriched during MASLD-to-MASLD-HCC progression and accelerated tumorigenesis in multiple mouse models, while its conditioned medium increased proliferation and reduced cell-cycle arrest and apoptosis in human MASLD-HCC cells; kynurenic acid (KYNA) was identified as the key metabolite and was elevated in portal vein/liver tissues/stools of treated mice, with KYNA promoting tumor progression (mechanism truncated). Scientifically, it implicates a specific microbiome–metabolite pathway (R. arrhizus → KYNA) in MASLD-HCC development, suggesting KYNA or its upstream fungal metabolism as potential intervention targets.

Zhou X, Liu C, Wei W et al. · Cell metabolism · (2026) · View on PubMed ↗ · Free PDF ↗

How climate change affects mosquito-borne infectious disease: The different trajectories of malaria and dengue.

This study examined how climate change alters mosquito-borne infectious disease transmission by comparing trajectories for malaria (Anopheles) and dengue (Aedes). It found that warming combined with rainfall and humidity can expand mosquito suitability and increase vector spread, but the climate–disease relationships are nonlinear, seasonally dependent, and highly location-specific due to nonclimate drivers. The significance is improved understanding of why malaria and dengue respond differently to climate drivers, informing more realistic forecasting and targeted public health planning.

Cumming TB, Surendra H, Leder K et al. · Science advances · (2026) · View on PubMed ↗ · Free PDF ↗

Dynamic tRNA modification programs align codon usage with growth-phase-specific gene expression in Pseudomonas aeruginosa.

This study investigated how dynamic tRNA modification programs coordinate codon usage with growth-phase–specific gene expression in Pseudomonas aeruginosa PA14. Using time-resolved nanopore tRNA sequencing, LC–MS/MS modification profiling, transcriptomics, and proteomics, it found a coordinated temporal cascade in which tRNA-modifying enzymes and their corresponding modifications align with growth-phase gene expression, exemplified by GidA-dependent mnm5s2U modifications. The significance is a mechanistic link between the bacterial “epitranscriptome” and translational control across growth, suggesting new targets for modulating bacterial adaptation.

Frommeyer YN, Sun J, Wu J et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗ · Free PDF ↗

Fusobacterium nucleatum enhances enterotoxigenic Bacteroides fragilis-mediated neuron loss and intestinal motility dysfunction.

This mouse mechanistic study investigated how Fusobacterium nucleatum influences enterotoxigenic Bacteroides fragilis (ETBF)–mediated neuron loss and intestinal motility dysfunction. It found that ETBF toxin (BFT) induces apoptosis of colonic myenteric neurons via the NOD1–RIPK2–CASP9–CASP3 pathway, and that gut dysmotility persists after ETBF clearance, with human cohort data showing positive correlation between ETBF and F. nucleatum abundance. The work is significant because it identifies a toxin-driven inflammatory mechanism and a microbial interaction that may contribute to long-term dysmotility in ETBF-associated disease.

Zhang Y, Zhao Y, Zhang L et al. · Nature microbiology · (2026) · View on PubMed ↗

A conserved archaeal protein with evolutionary links to bacterial ribosome hibernation and eukaryotic energy sensing.

This study characterized a conserved archaeal ribosome-associated factor, AHA (AMPKγ-HPF from Archaea), and its evolutionary links to bacterial ribosome hibernation and eukaryotic energy sensing. Using cryoEM of archaeal lysates, the authors showed AHA binds across ribosomal subunits to occlude the mRNA channel and tRNA binding sites, and ΔAHA cells exhibited reduced viability, stationary-phase ribosomal protein loss, and impaired growth reentry. The findings are significant because they define a conserved mechanism of archaeal translation hibernation and connect it to broader energy-sensing biology.

Souza DP, May MB, Carrion J et al. · The EMBO journal · (2026) · View on PubMed ↗ · Free PDF ↗

---

---

Generated automatically on October 04, 2026 from PubMed’s trending articles. Summaries are AI-generated; always consult the original publication for clinical or research decisions.